Clinical Trial Update: PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial assessing the pharmacokinetics, safety, and preliminary efficacy of montelukast in critically ill infants with developing bronchopulm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Critical Illness
• Premature Birth

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: Duke University | Conditions: Bronchopulmonary Dysplasia (BPD), Premature Births | Phase 1, Phase 2 | Status: RECRUITING